DEA Schedule CII

Strength

1.5; 5 mg/5mL; mg/5mL

Manufacturer

KVK-Tech Inc.

NDC

10702015016

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207487

On Market Since

2/21/2017

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price History

1W

0.0%

1M

-0.4%

3M

+1.3%

6M

+5.6%

1Y

-3.6%

3Y

+65.1%

5Y

+3.7%

All

+5.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.